Skip to main content
. 2019 Jun 2;10(13):2868–2873. doi: 10.7150/jca.31260

Figure 1.

Figure 1

The overall survival (OS) for all patients at 2 years was 38.4%, with a median survival time of 18.6 months (Fig.1a) .The progression-free survival (PFS) rate in all patients at 2 years was 18.2%, with a median PFS time of 7.6 months (Fig.1b).